MSD
The Computational Toxicology group within Nonclinical Drug Safety seeks a Postdoctoral Fellow to advance AI/ML and structure-based approaches for immunogenicity prediction in biologic and peptide therapeutics. The role involves developing next-generation computational methods combining protein structure modeling, immunoinformatics, and multimodal machine learning to improve prediction of biologically relevant immune responses. This is a publication-oriented, two-year fellowship with strong mentorship and extensive cross-functional and external academic collaboration.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Postdoctoral Fellow
Merck & Co., Inc.
Protein Bioinformatics - Postdoctoral Researcher
LLNL
Protein Bioinformatics - Postdoctoral Researcher
LLNL
Post Doc Fellow in Immunogenicity Prediction
Merck & Co., Inc.
Protein Bioinformatics - Postdoctoral Researcher
LLNL
Postdoctoral Scientist (Computational & Structural Bioinformatics)
Gilead Sciences